Results 271 to 280 of about 309,278 (337)
Assessment of Genetic Diversity in Chokla Sheep Breed of Rajasthan Using Microsatellite Markers
Kritika Gahlot +3 more
openalex +1 more source
Abstract Metabolic alterations and immune dysfunction within the gastric tumor microenvironment critically drive gastric cancer (GC) progression and therapeutic resistance. Although single‐cell RNA sequencing (scRNA‐seq) has unveiled cellular heterogeneity in GC, the metabolic landscapes of tumor cells and their interplay with immune components remain ...
Junjun Liu +7 more
wiley +1 more source
Characterization and genetic diversity analysis of lesser-known goat population of northern hills of Chhattisgarh. [PDF]
Bhagat V +7 more
europepmc +1 more source
Abstract Objectives This study aimed to evaluate the successful sequencing rate of Foundation One CDx (F1CDx) using small tissue samples obtained with a 22‐gauge needle (22G) through endoscopic ultrasound‐guided fine needle acquisition (EUS‐TA) and to propose guidelines for tissue quantity evaluation criteria and proper slide preparation in clinical ...
Tami Nagatani +11 more
wiley +1 more source
Genetic diversity and genotyping of <i>Echinococcus multilocularis</i>: a minireview. [PDF]
Rachel F, Conraths FJ, Maksimov P.
europepmc +1 more source
Development and Validation of Tetranucleotide Repeat Microsatellite Markers at the Whole-Genome Level in the Yangtze Finless Porpoise. [PDF]
Tang M +10 more
europepmc +1 more source
Natural History of Duodenal Adenoma: An 11‐year Follow‐up
ABSTRACT Early detection and treatment are essential to decrease the mortality rate of duodenal cancer (DC). However, the natural history of DC remains unclear. A 78‐year‐old woman underwent screening esophagogastroduodenoscopy (EGD) before surgery for advanced colon cancer.
Hikaru Kuribara +8 more
wiley +1 more source
Metastatic organ count stratifies survival in immunotherapy-treated metastatic colorectal cancer: a retrospective cohort study. [PDF]
Fu HY +7 more
europepmc +1 more source
What's new? CATCH is a prospective precision oncology registry trial that harnesses whole‐genome/exome‐ and RNA‐sequencing to enable actionable biomarker detection in metastatic breast cancer patients of any subtype. The data of the first 412 consecutive patients with completed follow‐up in this real‐world, single‐center patient cohort provide robust ...
Mario Hlevnjak +31 more
wiley +1 more source

